Stock Analiz

Outset Medical, Inc. OM

Biotechnology: Electromedical & Electrotherapeutic Apparatus · IPO 2020 · data as of November 13, 2026

$3.73Market cap $70M
Open the interactive analysis →

Outset Medical, Inc. (OM) is a healthcare company listed in the US with a market value of about $70M. In the twelve months to September 30, 2026 it had revenue of $122M and net income of -$71M, a net margin of -58.3%.

Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is future growth (2/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of 19% a year, a 5-year average ROIC of -35%.

About Outset Medical

Outset Medical is listed in the US and classified in biotechnology: electromedical & electrotherapeutic apparatus, IPO year 2020. Revenue went from $2M in 2018 to $119M in 2025, growth of about 79.3% a year. It was profitable in 0 of the last 8 years in our data. Its share count rose by 374% over three years (dilution for shareholders). It spends 18% of revenue on research and development.

Score: 1.0 / 5

Value0/5
Future growth2/5
Track record1/5
Financial health2/5
Shareholder returns0/5

Checks passed

  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • 5-year revenue growth above 8% a year
  • More cash than debt, or low debt to equity
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S0.6
P/B0.8
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-60.9%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)5.1%
Revenue growth (5 yrs, per year)19.1%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-116.7%
ROIC (5-yr avg.)-35.0%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 8 years

Fiscal yearTTM20252024202320222021202020192018
Revenue$122M$119M$114M$130M$115M$103M$50M$15M$2M
Net income-$71M-$82M-$128M-$173M-$163M-$132M-$121M-$68M-$50M
Free cash flow-$43M-$47M-$117M-$135M-$154M-$133M-$108M-$74M-$48M
EPS (diluted)$-3.78$-5.37$-36.96$-52.28$-50.71$-43.36$-72.77$-1494.09$-1511.65
Net margin-58.3%-68.3%-112.6%-132.5%-141.2%-128.6%-243.3%-453.0%-2480.3%
ROIC—-23.1%-39.2%-51.8%-35.9%-24.9%-31.8%——

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Does Outset Medical pay a dividend?

Not currently.

Is Outset Medical a good stock to buy?

We do not give buy or sell advice. Outset Medical scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.